Literature DB >> 1349134

High-dose meropenem in meningitis due to Pseudomonas aeruginosa.

J P Donnelly, A M Horrevorts, R W Sauerwein, B E De Pauw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1349134     DOI： 10.1016/0140-6736(92)90714-e

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Neurotoxicity of carbapenem antibacterials.

Authors:  S R Norrby
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

2.  Treatment of Bacterial Meningitis.

Authors:  Allan R. Tunkel; W. Michael Scheld
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 3.  Meropenem clinical pharmacokinetics.

Authors:  J W Mouton; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

4.  Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.

Authors:  R Nau; C Lassek; M Kinzig-Schippers; A Thiel; H W Prange; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 5.  Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; A J Wagstaff; R N Brogden; H M Bryson
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

6.  Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group.

Authors:  K P Klugman; R Dagan
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.